SYNCOM FORMU (I) LTD (SYNCOMF) financials

SYNCOM FORMU (I) LTD (SYNCOMF) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.[1]

  • Market Cap: ₹2,063Cr.
  • Current Price: ₹22.0
  • Stock P/E: 24.3
  • ROE: 17.6%
  • ROCE: 24.8%
  • Book Value: ₹4.39
  • Dividend Yield: 0.46%
  • 52W High / Low: ₹27.5/10.2

In Jun 2026, SYNCOM FORMU (I) LTD (SYNCOMF) reported sales ₹125 Cr and net profit ₹25 Cr.

Annual TTM: sales ₹495 Cr, net profit ₹85 Cr.

Shareholding: Promoters 50.57% (Sep 2026), FIIs 2.23% (Sep 2026), Public 47.20% (Sep 2026), No. of Shareholders 4,18,465% (Sep 2026).

SYNCOMF quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales101127148117121115134125
Expenses901121311011039311399
Operating Profit1215171619212126
OPM %12%11%12%14%15%18%16%21%
Other Income447655148
Interest00000000
Depreciation11111122
Profit before tax1517232022253332
Tax %25%24%24%22%25%25%25%23%
Net Profit1113181617192525
EPS in Rs0.120.140.190.170.180.200.260.26
Raw PDF————————
SYNCOMF profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales206245216222257461486495
Expenses189207196202229407409407
Operating Profit1738202028547787
OPM %8%16%9%9%11%12%16%18%
Other Income57121513173133
Interest10235111
Depreciation44455577
Profit before tax174126273265101112
Tax %18%28%24%24%26%24%24%—
Net Profit1429202024497685
EPS in Rs0.180.370.230.210.250.520.810.90
Dividend Payout %0%0%13%0%0%0%12%—
SYNCOMF balance sheet (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital7878798694949494
Reserves5568109136162192246318
Borrowings926258837241
Other Liabilities32334228383366116
Total Liabilities173181292308377392410529
Fixed Assets8993919491120125184
CWIP000626000
Investments211143646693109
Other Assets8387189165196206192237
Total Assets173181292308377392410529
SYNCOMF cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity46-21610-62358
Cash from Investing Activity22-75-27-4584-18-51
Cash from Financing Activity-0-772835-15-68-3
Net Cash Flow71-5-2163-634
Free Cash Flow104-55-10-141347
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit66%61%24%113%86%6%70%105%
SYNCOMF shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters50.57%50.57%50.57%50.57%50.57%50.57%50.57%50.57%
FIIs0.13%0.11%0.41%0.10%0.26%0.21%0.35%2.23%
Public49.30%49.32%49.02%49.33%49.17%49.23%49.07%47.20%
No. of Shareholders4,89,5204,84,5294,71,0664,57,3644,42,2804,31,6904,22,1144,18,465
SYNCOMF key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days81771121141241328581
Inventory Days3739515153494981
Days Payable5749663652335296
Cash Conversion Cycle6167961291241488166
Working Capital Days74882833-4519585
ROCE %9%12%21%11%10%10%19%25%
SYNCOMFUpdated 18 Oct 2026, 20:00

Syncom Formu (i) Ltd

Market Cap

₹2,063Cr.

Current Price

₹22.0

High / Low

₹27.5/10.2

Stock P/E

24.3

ROE17.6%
ROCE24.8%
Book Value₹4.39
Face Value₹1.00
Dividend Yield0.46%

About

Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6691918781771121141241328581
Inventory Days344329373739515153494981
Days Payable6313092755749663652335296
Cash Conversion Cycle37427496167961291241488166
Working Capital Days8440457574882833-4519585
ROCE %16%15%14%9%9%12%21%11%10%10%19%25%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SYNCOM FORMU (I) LTD (SYNCOMF)?

The reported market capitalisation for SYNCOM FORMU (I) LTD (SYNCOMF) is ₹2,063Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SYNCOMF?

The current price shown for SYNCOM FORMU (I) LTD (SYNCOMF) on Fincrux is ₹22.0 with a 52-week high/low of ₹27.5/10.2.

What is the P/E ratio of SYNCOM FORMU (I) LTD (SYNCOMF)?

The stock P/E for SYNCOM FORMU (I) LTD (SYNCOMF) is 24.3 on Fincrux, with ROE at 17.6% and ROCE at 24.8%.

What were SYNCOMF latest quarterly results?

For Jun 2026, SYNCOM FORMU (I) LTD (SYNCOMF) reported sales ₹125 Cr and net profit ₹25 Cr (figures in ₹ crore unless noted).

What are SYNCOMF annual sales and net profit?

For TTM, SYNCOM FORMU (I) LTD (SYNCOMF) shows sales of ₹495 Cr and net profit of ₹85 Cr on the Fincrux profit & loss statement.

Who owns SYNCOM FORMU (I) LTD (SYNCOMF)?

Latest shareholding for SYNCOM FORMU (I) LTD (SYNCOMF) on Fincrux: Promoters 50.57% (Sep 2026), FIIs 2.23% (Sep 2026), Public 47.20% (Sep 2026), No. of Shareholders 4,18,465% (Sep 2026).

Where can I find SYNCOM FORMU (I) LTD (SYNCOMF) financials?

SYNCOM FORMU (I) LTD (SYNCOMF) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SYNCOMF balance sheet and cash flow?

Yes. The SYNCOM FORMU (I) LTD (SYNCOMF) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 20:00


Designed & Shipped by Harshit Bansal